BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37846319)

  • 1. The clinical application of critical flicker fusion frequency in demyelinating optic neuritis.
    Fu J; Wang Y; Tan S; Xu G; Zhou H; Xu Q; Wei S
    Adv Ophthalmol Pract Res; 2021 Dec; 1(2):100011. PubMed ID: 37846319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical flicker fusion frequency in demyelinating and ischemic optic neuropathies.
    Young MT; Braich PS; Haines SR
    Int Ophthalmol; 2018 Jun; 38(3):1069-1077. PubMed ID: 28527029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical characteristics of myelin oligodendrocyte glycoprotein antibody-positive optic neuritis].
    Song HL; Wei SH
    Zhonghua Yan Ke Za Zhi; 2019 Mar; 55(3):174-179. PubMed ID: 30841683
    [No Abstract]   [Full Text] [Related]  

  • 4. Trichromatic critical flicker frequency as potential visual test in cataract and macula disease patients.
    Xu G; Luo Y; Qi H; Liu S; Fu J; Ye Z; Li Z
    Graefes Arch Clin Exp Ophthalmol; 2024 Feb; ():. PubMed ID: 38329529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical flicker frequency in acute and recovered optic neuritis.
    Woung LC; Wakakura M; Ishikawa S
    Jpn J Ophthalmol; 1993; 37(2):122-9. PubMed ID: 8230835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the retinal vascular network and structure in patients with optic neuritis associated with myelin oligodendrocyte glycoprotein or aquaporin-4 antibodies: an optical coherence tomography angiography study.
    Yu J; Huang Y; Zhou L; ZhangBao J; Zong Y; Quan C; Wang M
    J Neurol; 2021 Dec; 268(12):4874-4881. PubMed ID: 34086096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal visual resolution and disease severity in MS.
    Ayadi N; Dörr J; Motamedi S; Gawlik K; Bellmann-Strobl J; Mikolajczak J; Brandt AU; Zimmermann H; Paul F
    Neurol Neuroimmunol Neuroinflamm; 2018 Sep; 5(5):e492. PubMed ID: 30175166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peripapillary and macular vessel density in eyes with different phases of thyroid-associated ophthalmopathy].
    Wang YH; Ma J; Li H; Xu HY; Gan LY; Zhang X; Wang XQ; Zhong Y
    Zhonghua Yan Ke Za Zhi; 2020 Nov; 56(11):824-831. PubMed ID: 33152840
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical characteristics of myelin oligodendrocyte glycoprotein seropositive optic neuritis: a cohort study in Shanghai, China.
    Zhao G; Chen Q; Huang Y; Li Z; Sun X; Lu P; Yan S; Wang M; Tian G
    J Neurol; 2018 Jan; 265(1):33-40. PubMed ID: 29101456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical characteristics, treatment and prognosis of myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in children].
    Hou C; Chen WX; Qiu W; Li XJ; Tian Y; Zhu HX; Zeng YR; Liang HC; Peng BW; Chen LF
    Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(9):685-689. PubMed ID: 32187912
    [No Abstract]   [Full Text] [Related]  

  • 11. Measurement of retinal nerve fiber layer thickness in optic atrophy eyes of patients with optic neuritis using optical coherence tomography.
    Wang XL; Yu T; Xia DZ; Zhang JS; Yan QC; Luo YH
    Graefes Arch Clin Exp Ophthalmol; 2010 Jul; 248(7):1013-8. PubMed ID: 20191363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients.
    Zhao Y; Tan S; Chan TCY; Xu Q; Zhao J; Teng D; Fu H; Wei S
    Br J Ophthalmol; 2018 Oct; 102(10):1372-1377. PubMed ID: 29363529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and prognosis of myelin oligodendrocyte glycoprotein antibody-seropositive paediatric optic neuritis in China.
    Song H; Zhou H; Yang M; Tan S; Wang J; Xu Q; Liu H; Wei S
    Br J Ophthalmol; 2019 Jun; 103(6):831-836. PubMed ID: 30049802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical flicker frequencies in MS patients with normal or abnormal pattern VEP.
    Salmi T
    Acta Neurol Scand; 1985 May; 71(5):354-8. PubMed ID: 4013659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the Correlation Between Visual Acuity and Critical Fusion Frequency in Acute Optic Neuritis Before and After Steroid Therapy.
    Tsumura R; Harada Y; Chuman H; Kiuchi Y
    Cureus; 2023 Dec; 15(12):e49965. PubMed ID: 38179351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical flicker-fusion frequency in age-related macular degeneration.
    Maier M; Groneberg T; Specht H; Lohmann CP
    Graefes Arch Clin Exp Ophthalmol; 2010 Mar; 248(3):409-13. PubMed ID: 20076964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of visual evoked potentials in dysthyroid optic neuropathy.
    Garip Kübler A; Halfter K; Reznicek L; Klingenstein A; Priglinger S; Rudolph G; Hintschich C
    Orbit; 2023 Oct; 42(5):475-480. PubMed ID: 36128945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Optic neuropathy in positive anti-MOG antibody syndrome].
    Merabtene L; Vignal Clermont C; Deschamps R
    J Fr Ophtalmol; 2019 Dec; 42(10):1100-1110. PubMed ID: 31732265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripapillary and Macular Vessel Density in Dysthyroid Optic Neuropathy: An Optical Coherence Tomography Angiography Study.
    Zhang T; Xiao W; Ye H; Chen R; Mao Y; Yang H
    Invest Ophthalmol Vis Sci; 2019 May; 60(6):1863-1869. PubMed ID: 31042792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual function in recovered ethambutol optic neuropathy.
    Woung LC; Jou JR; Liaw SL
    J Ocul Pharmacol Ther; 1995; 11(3):411-9. PubMed ID: 8590273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.